Fundz

E2 Appoints Justin Farry as Chief Financial Officer

PRIVATESep 02, 2025

Position

Chief Financial Officer

Company

Endovascular Engineering

Justin Farry
Menlo ParkBiotechnologyHealth CareMedical Devicemedical devices

Description

E2 has announced the appointment of Justin Farry as its new Chief Financial Officer. Farry brings over 25 years of expertise in financial strategy and MedTech operations at a critical stage of growth for the company.

Quick answer

E2 Appoints Justin Farry as Chief Financial Officer (September 2, 2025). Endovascular Engineering is based in Menlo Park, California, United States.

Who is the new Chief Financial Officer at Endovascular Engineering?
Endovascular Engineering named Justin Farry Chief Financial Officer, announced September 2, 2025.
What did Endovascular Engineering announce on September 2, 2025?
E2 has announced the appointment of Justin Farry as its new Chief Financial Officer. Farry brings over 25 years of expertise in financial strategy and MedTech operations at a critical stage of growth for the company.
What does Endovascular Engineering do?
Endovascular Engineering, Inc. ("E2") is at the forefront of transforming venous thromboembolism (VTE) treatment with the Hēlo™ Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism.
Where is Endovascular Engineering based?
Endovascular Engineering is based in Menlo Park, California, United States.
Which similar companies made leadership changes around the same time?
Avania (September 4, 2025), Insulet (August 25, 2025), MED-X (August 21, 2025) and CMR Surgical (August 19, 2025) also announced leadership changes within 45 days of Endovascular Engineering.

Source: Fundz verified event record.

Other recent leadership changes in Medical Device and medical devices

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Endovascular Engineering, and when

A new leader at Endovascular Engineering brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Endovascular Engineering raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Endovascular Engineering, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Endovascular Engineering. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Endovascular Engineering

Location

3925 Bohannon Dr

Menlo Park, California, United States

About

Endovascular Engineering, Inc. ("E2") is at the forefront of transforming venous thromboembolism (VTE) treatment with the Hēlo™ Thrombectomy System, a novel technology designed for the treatment of pulmonary embolism. As a venture-backed medical technology innovator with multiple strategic investors, E2 is dedicated to developing and deploying groundbreaking solutions that advance the standard of care in clot removal. The company's technology platform represents the convergence of clinical insight and engineering excellence, aimed at addressing the complex challenges in VTE intervention.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Endovascular Engineering changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Dan
Likely contact at this company
••••••••@••••••••

See Dan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Endovascular Engineering's next move

Learn about Strategic plan

Endovascular Engineering changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.